Doyle John's Insider Trades & SAST Disclosures
Doyle John's most recent trade in Marsh & McLennan Cos., Inc. was a trade of 26,426 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Doyle John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 26,426 | 101,172 (0%) | 0% | 0 | Common Stock | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 26,426 | 0 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Sale of securities on an exchange or to another person at price $ 237.05 per share. | 28 Feb 2025 | 21,080 | 87,681 (0%) | 0% | 237.1 | 4,997,014 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.09 per share. | 28 Feb 2025 | 21,080 | 108,761 (0%) | 0% | 63.1 | 1,329,937 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 21,080 | 63,238 | - | - | Stock Options (Right to Buy) | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 233.74 per share. | 28 Feb 2025 | 13,491 | 87,681 (0%) | 0% | 233.7 | 3,153,386 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 146,112 | 146,112 | - | - | Stock Options (Right to Buy) | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 26,426 | 26,426 | - | - | Restricted Stock Units | |
|
Cognition Therapeutics Inc
Board Meeting |
John Doyle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 15 Feb 2025 | 1,723 | 414,402 | - | 0.6 | 1,017 | Common Stock |
|
Icad Inc
Board Meeting |
Michael John Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 7,482 | 7,482 | - | - | Director Stock Option (right to buy) | |
|
Cognition Therapeutics Inc
Board Meeting |
John Doyle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 295,000 | 416,125 | - | 0 | Common Stock | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 212.09 per share. | 15 Jan 2025 | 5,762 | 77,008 (0%) | 0% | 212.1 | 1,222,034 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 5,762 | 0 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.08 per share. | 15 Jan 2025 | 2,262 | 74,746 (0%) | 0% | 212.1 | 479,736 | Common Stock |
|
Icad Inc
Board Meeting |
Michael John Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 30,000 | 30,000 | - | - | Director Stock Option (right to buy) | |
|
Verde Clean Fuels Inc - Or...
|
John R. Doyle | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 310,985 | 310,985 | - | - | Employee Stock Option (Right to Buy) | |
|
Cognition Therapeutics Inc
Board Meeting |
John Doyle | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.95 per share. | 01 May 2024 | 8,699 | 121,125 | - | 1.9 | 16,963 | Common Stock |
|
Icad Inc
Board Meeting |
Michael John Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 9,874 | 9,874 | - | - | Director Stock Option (right to buy) | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 28,930 | 5,762 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
Q. John Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 28,930 | 86,015 (0%) | 0% | 0 | Common Stock | |
|
Marsh & McLennan Cos., Inc.
|
Q. Doyle John | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.98 per share. | 28 Feb 2024 | 14,769 | 71,246 (0%) | 0% | 203.0 | 2,997,885 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
Q. Doyle John | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 138,063 | 138,063 | - | - | Stock Options (Right to Buy) | |
|
Marsh & McLennan Cos., Inc.
|
Doyle Q. John | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 28,930 | 34,692 | - | - | Restricted Stock Units | |
|
Cognition Therapeutics Inc
Board Meeting |
John Doyle | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
|
Cognition Therapeutics Inc
Board Meeting |
Doyle John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 20,000 | 129,824 | - | 0 | Common Stock | |
|
Icad Inc
Board Meeting |
Michael Doyle John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 40,000 | 40,000 | - | - | Director Stock Option (right to buy) | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 5,682 | 9,668 (0%) | 0% | 0 | Common | |
|
Verde Clean Fuels Inc - Or...
|
John R. Doyle | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 334,021 | 334,021 | - | - | Employee Stock Option (Right to Buy) | |
|
Exponent Inc.
|
John Joseph Doyle | Group Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 2,400 | 2,400 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 26,922 | 70,829 (0%) | 0% | 0 | Common Stock | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 26,922 | 5,762 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.83 per share. | 28 Feb 2023 | 13,744 | 57,085 (0%) | 0% | 162.8 | 2,237,936 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 132,387 | 132,387 | - | - | Stock Options (Right to Buy) | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 26,922 | 32,684 | - | - | Restricted Stock Units | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Purchase of securities on an exchange or from another person at price $ 12.55 per share. | 30 Jan 2023 | 4,000 | 44,600 (0%) | 0% | 12.6 | 50,200 | Common |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2022 | 3,000 | 40,600 (0%) | 0% | 0 | Common | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Aug 2022 | 3,000 | 3,986 (0%) | 0% | 0 | Common | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 3,986 | 6,986 (0%) | 0% | 0 | Common | |
|
Exponent Inc.
|
John Joseph Doyle | Group Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 2,544 | 2,544 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 17,608 | 5,762 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 17,608 | 52,897 (0%) | 0% | 0 | Common Stock | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.98 per share. | 28 Feb 2022 | 8,990 | 43,907 (0%) | 0% | 154.0 | 1,384,325 | Common Stock |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 63,738 | 63,738 | - | - | Stock Options (Right to Buy) | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 15,037 | 23,370 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | Group President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 5,762 | 8,333 | - | - | Restricted Stock Units | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2021 | 3,000 | 3,000 (0%) | 0% | 0 | Common | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2021 | 3,000 | 37,600 (0%) | 0% | 0 | Common | |
|
Brookline Bancorp, Inc.
|
John J. Doyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 3,000 | 6,000 (0%) | 0% | 0 | Common | |
|
Exponent Inc.
|
John Joseph Doyle | Group Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 8,389 | 8,389 | - | - | Restricted Stock Units | |
|
Marsh & McLennan Cos., Inc.
|
John Q. Doyle | President and CEO, Marsh | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2021 | 14,222 | 42,255 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges